Fisher Historical Income Statement

FPH Stock

34.52 0.67 1.98%

Historical analysis of Fisher Paykel income statement accounts such as Selling General Administrative of 517.4 M or Total Revenue of 1.8 B can show how well Fisher Paykel Healthcare performed in making a profits. Evaluating Fisher Paykel income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Fisher Paykel's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Fisher Paykel Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fisher Paykel Healthcare is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fisher Paykel Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Fisher Income Statement Analysis

Fisher Paykel Healthcare Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Fisher Paykel shareholders. The income statement also shows Fisher investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Fisher Paykel Income Statement Chart

At this time, Fisher Paykel's Net Income is comparatively stable compared to the past year. Depreciation And Amortization is likely to gain to about 96 M in 2024, whereas Income Before Tax is likely to drop slightly above 194 M in 2024.

Selling General Administrative Operating Income Net Income From Continuing Ops Income Before Tax

Operating Income

Operating Income is the amount of profit realized from Fisher Paykel Healthcare operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Fisher Paykel Healthcare is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Fisher Paykel income statement and is an important metric when analyzing Fisher Paykel Healthcare profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most accounts from Fisher Paykel's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Fisher Paykel Healthcare current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fisher Paykel Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Gross Profit	938.7M	885.3M	1.0B	1.1B
Total Revenue	1.5B	1.5B	1.7B	1.8B

Gross Profit Total Revenue

Fisher Paykel income statement Correlations

	Discontinued Operations	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Operating Income	Net Income From Continuing Ops	Ebit	Cost Of Revenue	Non Recurring	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Depreciation And Amortization	Selling And Marketing Expenses	Other Operating Expenses	Research Development	Ebitda	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation
Discontinued Operations		0.47	-0.23	0.43	0.3	0.31	0.34	0.33	0.61	-0.28	0.66	0.32	-0.2	0.3	0.37	0.47	0.59	0.61	0.55	0.39	0.23	-0.34	-0.26	0.29
Interest Expense	0.47		0.62	0.52	0.45	0.1	-0.07	0.05	0.61	-0.82	0.68	-0.05	-0.65	-0.11	0.16	0.51	0.59	0.65	0.68	0.09	0.15	-0.13	-0.87	0.52
Selling General Administrative	-0.23	0.62		0.32	0.35	-0.14	-0.32	-0.2	0.26	-0.82	0.32	-0.3	-0.7	-0.36	-0.08	0.22	0.29	0.32	0.41	-0.19	0.05	-0.08	-0.85	0.37
Total Revenue	0.43	0.52	0.32		0.98	0.79	0.72	0.78	0.96	-0.56	0.93	0.72	-0.83	0.68	0.82	0.96	0.96	0.96	0.94	0.81	0.8	-0.71	-0.57	0.89
Gross Profit	0.3	0.45	0.35	0.98		0.82	0.72	0.78	0.9	-0.52	0.87	0.74	-0.85	0.7	0.82	0.92	0.92	0.9	0.9	0.8	0.81	-0.73	-0.52	0.85
Operating Income	0.31	0.1	-0.14	0.79	0.82		0.91	0.97	0.7	0.0	0.62	0.95	-0.53	0.93	0.96	0.73	0.7	0.67	0.61	0.97	0.86	-0.66	-0.05	0.64
Net Income From Continuing Ops	0.34	-0.07	-0.32	0.72	0.72	0.91		0.96	0.66	0.05	0.53	0.99	-0.34	0.99	0.92	0.68	0.6	0.6	0.5	0.94	0.89	-0.6	0.11	0.53
Ebit	0.33	0.05	-0.2	0.78	0.78	0.97	0.96		0.72	0.02	0.59	0.99	-0.45	0.96	0.98	0.73	0.66	0.66	0.57	1.0	0.92	-0.62	-0.02	0.65
Cost Of Revenue	0.61	0.61	0.26	0.96	0.9	0.7	0.66	0.72		-0.59	0.97	0.66	-0.74	0.61	0.76	0.96	0.95	0.99	0.96	0.76	0.73	-0.65	-0.61	0.89
Non Recurring	-0.28	-0.82	-0.82	-0.56	-0.52	0.0	0.05	0.02	-0.59		-0.66	0.09	0.76	0.14	-0.1	-0.5	-0.6	-0.64	-0.69	-0.01	-0.22	0.26	0.92	-0.48
Total Operating Expenses	0.66	0.68	0.32	0.93	0.87	0.62	0.53	0.59	0.97	-0.66		0.53	-0.78	0.48	0.65	0.93	0.98	0.99	0.99	0.65	0.58	-0.67	-0.67	0.84
Income Before Tax	0.32	-0.05	-0.3	0.72	0.74	0.95	0.99	0.99	0.66	0.09	0.53		-0.36	0.99	0.96	0.68	0.61	0.6	0.5	0.98	0.9	-0.62	0.09	0.56
Total Other Income Expense Net	-0.2	-0.65	-0.7	-0.83	-0.85	-0.53	-0.34	-0.45	-0.74	0.76	-0.78	-0.36		-0.3	-0.54	-0.7	-0.81	-0.78	-0.81	-0.47	-0.57	0.55	0.78	-0.7
Net Income	0.3	-0.11	-0.36	0.68	0.7	0.93	0.99	0.96	0.61	0.14	0.48	0.99	-0.3		0.92	0.65	0.57	0.55	0.45	0.95	0.87	-0.59	0.17	0.5
Income Tax Expense	0.37	0.16	-0.08	0.82	0.82	0.96	0.92	0.98	0.76	-0.1	0.65	0.96	-0.54	0.92		0.75	0.71	0.72	0.62	0.98	0.95	-0.68	-0.16	0.67
Depreciation And Amortization	0.47	0.51	0.22	0.96	0.92	0.73	0.68	0.73	0.96	-0.5	0.93	0.68	-0.7	0.65	0.75		0.94	0.96	0.95	0.78	0.7	-0.66	-0.52	0.93
Selling And Marketing Expenses	0.59	0.59	0.29	0.96	0.92	0.7	0.6	0.66	0.95	-0.6	0.98	0.61	-0.81	0.57	0.71	0.94		0.98	0.98	0.7	0.64	-0.75	-0.6	0.83
Other Operating Expenses	0.61	0.65	0.32	0.96	0.9	0.67	0.6	0.66	0.99	-0.64	0.99	0.6	-0.78	0.55	0.72	0.96	0.98		0.98	0.71	0.67	-0.67	-0.65	0.88
Research Development	0.55	0.68	0.41	0.94	0.9	0.61	0.5	0.57	0.96	-0.69	0.99	0.5	-0.81	0.45	0.62	0.95	0.98	0.98		0.62	0.57	-0.67	-0.7	0.88
Ebitda	0.39	0.09	-0.19	0.81	0.8	0.97	0.94	1.0	0.76	-0.01	0.65	0.98	-0.47	0.95	0.98	0.78	0.7	0.71	0.62		0.9	-0.64	-0.06	0.7
Tax Provision	0.23	0.15	0.05	0.8	0.81	0.86	0.89	0.92	0.73	-0.22	0.58	0.9	-0.57	0.87	0.95	0.7	0.64	0.67	0.57	0.9		-0.62	-0.22	0.65
Interest Income	-0.34	-0.13	-0.08	-0.71	-0.73	-0.66	-0.6	-0.62	-0.65	0.26	-0.67	-0.62	0.55	-0.59	-0.68	-0.66	-0.75	-0.67	-0.67	-0.64	-0.62		0.24	-0.53
Net Interest Income	-0.26	-0.87	-0.85	-0.57	-0.52	-0.05	0.11	-0.02	-0.61	0.92	-0.67	0.09	0.78	0.17	-0.16	-0.52	-0.6	-0.65	-0.7	-0.06	-0.22	0.24		-0.62
Reconciled Depreciation	0.29	0.52	0.37	0.89	0.85	0.64	0.53	0.65	0.89	-0.48	0.84	0.56	-0.7	0.5	0.67	0.93	0.83	0.88	0.88	0.7	0.65	-0.53	-0.62

Click cells to compare fundamentals

Fisher Paykel Account Relationship Matchups

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Fisher Stock Analysis

When running Fisher Paykel's price analysis, check to measure Fisher Paykel's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fisher Paykel is operating at the current time. Most of Fisher Paykel's value examination focuses on studying past and present price action to predict the probability of Fisher Paykel's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fisher Paykel's price. Additionally, you may evaluate how the addition of Fisher Paykel to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Fisher Historical Income Statement

About Fisher Income Statement Analysis

Fisher Paykel Income Statement Chart

Operating Income

Income Before Tax

Fisher Paykel income statement Correlations

Fisher Paykel Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Fisher Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ebitda	+ 1.0	Ebit
Income Before Tax	+ 0.99	Net Income From Continuing Ops
Net Income	+ 0.99	Net Income From Continuing Ops
Income Before Tax	+ 0.99	Ebit
Other Operating Expenses	+ 0.99	Cost Of Revenue
Other Operating Expenses	+ 0.99	Total Operating Expenses

Net Interest Income	- 0.87	Interest Expense
Total Other Income Expense Net	- 0.85	Gross Profit
Net Interest Income	- 0.85	Selling General Administrative
Total Other Income Expense Net	- 0.83	Total Revenue
Non Recurring	- 0.82	Selling General Administrative
Non Recurring	- 0.82	Interest Expense